Nexentis subsidiary achieves drug discovery milestone

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to Nexentis subsidiary achieves drug discovery milestone
(NASDAQ: NXTS) Delayed: 1.72 -0.04 (2.27%)
Previous Close $1.76    52 Week High $ 
Open $1.76    52 Week Low $ 
Day High $1.89    P/E N/A 
Day Low $1.61    EPS $ 
Volume 31,989